Clinical Trials Directory

Trials / Completed

CompletedNCT05613725

OptiGon - Optimising Laboratory Assays for Immune Responses to Gonococcus

Optimising Laboratory Assays for Immune Responses to Gonococcus

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This is an observational study. Blood from otherwise healthy patients presenting with confirmed N.gonorrhoea infection, prior to treatment, will be collected to (i) allow the optimisation of assays assessing the immune response to gonococcus and (ii) assess whether N. gonorrhea specific responses can be detected on ELIspot +/- flow cytometry. The investigators plan to recruit up to 30 adults (men and women, aged 18-50 years) who have been diagnosed with confirmed N.gonorrhoea infection at the Sexual Health Clinic at the Oxford University Hospitals NHS Foundation Trust. The investigators will collect blood samples from consenting participants prior to them receiving curative antibiotic treatment.

Detailed description

On the day the patient attends the Sexual Health Clinic, they will be given the PIS to consider participation to the study following a confirmed positive result for N. gonorrhoea infection. Following written informed consent, a venous blood sample will be collected (up to 26 ml) on the same day. This will conclude that participant's involvement to the study. The blood sample will be transported to the laboratory at the Jenner Institute, University of Oxford for further analysis.

Conditions

Interventions

TypeNameDescription
OTHERBlood sample collectionBlood sample collection

Timeline

Start date
2022-12-02
Primary completion
2024-04-30
Completion
2024-04-30
First posted
2022-11-14
Last updated
2024-05-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05613725. Inclusion in this directory is not an endorsement.

OptiGon - Optimising Laboratory Assays for Immune Responses to Gonococcus (NCT05613725) · Clinical Trials Directory